Correction to: Clinical implications of prospective genomic profiling of metastatic breast cancer patients
Main Authors: | Courtney T. van Geelen, Peter Savas, Zhi Ling Teo, Stephen J. Luen, Chen-Fang Weng, Yi-An Ko, Keilly S. Kuykhoven, Franco Caramia, Roberto Salgado, Prudence A. Francis, Sarah-Jane Dawson, Stephen B. Fox, Andrew Fellowes, Sherene Loi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Breast Cancer Research |
Online Access: | https://doi.org/10.1186/s13058-022-01539-7 |
Similar Items
-
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study.
by: Andjelija Zivanovic Bujak, et al.
Published: (2020-10-01) -
Circulating tumour DNA in metastatic breast cancer to guide clinical trial enrolment and precision oncology: A cohort study
by: Andjelija Zivanovic Bujak, et al.
Published: (2020-10-01) -
Correction: The Subclonal Architecture of Metastatic Breast Cancer: Results from a Prospective Community-Based Rapid Autopsy Program "CASCADE".
by: Peter Savas, et al.
Published: (2017-04-01) -
Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer
by: Zhi Ling Teo, et al.
Published: (2023-08-01) -
Combining Radiotherapy and Immunotherapy in Metastatic Breast Cancer: Current Status and Future Directions
by: Steven David, et al.
Published: (2022-03-01)